Pei Hu

3.2k total citations
222 papers, 2.6k citations indexed

About

Pei Hu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Pei Hu has authored 222 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 49 papers in Oncology and 46 papers in Pharmacology. Recurrent topics in Pei Hu's work include Analytical Methods in Pharmaceuticals (27 papers), Lung Cancer Treatments and Mutations (21 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Pei Hu is often cited by papers focused on Analytical Methods in Pharmaceuticals (27 papers), Lung Cancer Treatments and Mutations (21 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Pei Hu collaborates with scholars based in China, United States and Switzerland. Pei Hu's co-authors include Ji Jiang, Dongyang Liu, Qian Zhao, Hongyun Wang, Chenggang Huang, Xiaoting Tian, Sheng Feng, Hongyun Wang, Xia Chen and Wen Zhong and has published in prestigious journals such as Circulation, Journal of Agricultural and Food Chemistry and Annals of Oncology.

In The Last Decade

Pei Hu

215 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei Hu China 26 778 589 439 392 307 222 2.6k
Ophelia Yin United States 28 433 0.6× 647 1.1× 199 0.5× 441 1.1× 99 0.3× 94 2.3k
Mark J. Rose United States 23 794 1.0× 334 0.6× 161 0.4× 239 0.6× 214 0.7× 49 2.7k
Thorir D. Bjornsson United States 28 466 0.6× 470 0.8× 207 0.5× 666 1.7× 148 0.5× 72 2.8k
Joachim Stangier Germany 37 442 0.6× 277 0.5× 225 0.5× 410 1.0× 216 0.7× 67 9.2k
Roland Valdes United States 29 840 1.1× 232 0.4× 287 0.7× 571 1.5× 74 0.2× 77 2.8k
Im‐Sook Song South Korea 36 1.4k 1.8× 1.4k 2.4× 250 0.6× 960 2.4× 106 0.3× 167 3.9k
Karl Zech Germany 30 636 0.8× 345 0.6× 693 1.6× 475 1.2× 177 0.6× 100 2.5k
Donald J. L. Jones United Kingdom 28 2.2k 2.8× 403 0.7× 226 0.5× 204 0.5× 81 0.3× 83 4.3k
Rashmi R. Shah United Kingdom 33 1.4k 1.8× 608 1.0× 389 0.9× 518 1.3× 55 0.2× 85 3.4k
David Jones United States 29 792 1.0× 819 1.4× 161 0.4× 679 1.7× 64 0.2× 58 2.4k

Countries citing papers authored by Pei Hu

Since Specialization
Citations

This map shows the geographic impact of Pei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Hu more than expected).

Fields of papers citing papers by Pei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Hu. The network helps show where Pei Hu may publish in the future.

Co-authorship network of co-authors of Pei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Hu. A scholar is included among the top collaborators of Pei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Hu. Pei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hanghang, et al.. (2023). LATS1/YAP1 Axis Controls Bone Regeneration on Distraction Osteogenesis by Activating Wnt/β-Catenin. Tissue Engineering Part A. 30(3-4). 154–167. 4 indexed citations
2.
Tian, Xiaoting, Hongwei Gao, Pei Hu, et al.. (2023). Pharmacokinetic and metabolite profile of orally administered anemoside B4 in rats with an improved exposure in formulations of rectal suppository. Journal of Ethnopharmacology. 315. 116694–116694. 5 indexed citations
3.
Yao, Xueting, Yupeng Ren, Qian Zhao, et al.. (2021). Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis. European Journal of Pharmaceutical Sciences. 159. 105704–105704. 15 indexed citations
4.
Li, Lei, Yangyang Wang, Yuxuan Zhao, et al.. (2021). Systematic investigation on the anti-rheumatoid arthritis material basis and mechanism of Juan Bi Tang. Part 1: Integrating metabolic profiles and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 202. 114133–114133. 8 indexed citations
5.
Liu, Xu, Hongzhong Liu, Haiyan Li, et al.. (2021). Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes. Frontiers in Endocrinology. 12. 694390–694390. 4 indexed citations
6.
7.
Xu, Xiao, Wanhong Xu, Wei Tang, et al.. (2016). AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients. Molecular Cancer Therapeutics. 15(11). 2586–2597. 69 indexed citations
8.
Zheng, Xin Xiao, et al.. (2016). Validation and Application of an LC–MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine. Journal of Chromatographic Science. 54(5). 713–719. 8 indexed citations
9.
Chen, Rui, Amin Rostami‐Hodjegan, Haotian Wang, et al.. (2016). Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6. European Journal of Pharmaceutical Sciences. 92. 131–136. 4 indexed citations
10.
Zhao, Qian, Yong Hou, Ji Jiang, et al.. (2016). Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT‐18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology. 82(1). 41–52. 18 indexed citations
11.
Zhao, Qian, Xia Chen, Yong Hou, et al.. (2015). Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus. The Journal of Clinical Pharmacology. 56(8). 948–959. 21 indexed citations
12.
Chen, Xia, Yong Hou, Ji Jiang, et al.. (2014). Pharmacokinetics, Pharmacodynamics, and Tolerability of Single Ascending Doses of RCT-18 in Chinese Patients with Rheumatoid Arthritis. Clinical Pharmacokinetics. 53(11). 1033–1044. 19 indexed citations
13.
Hu, Pei. (2013). Albite granites in Taoxinghu ophiolite in central Qiangtang, Qinghai-Tibet Plateau,China: Evidences of Paleo-Tethys oceanic crust subduction. Acta Petrologica Sinica. 15 indexed citations
14.
Hu, Pei. (2010). Petrogenetic and ore-forming processes of Huangshandong Cu-Ni sulfide deposit in Hami,Xinjiang. Mineralium Deposita. 3 indexed citations
15.
Jiang, Ji, Dongyang Liu, & Pei Hu. (2009). Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.. PubMed. 64(5). 323–6. 6 indexed citations
16.
Zhao, Qian, Ji Jiang, Xiaoming Li, Zhihong Lu, & Pei Hu. (2007). Single‐dose pharmacokinetics of levetiracetam in healthy Chinese male subjects. British Journal of Clinical Pharmacology. 63(5). 614–617. 19 indexed citations
17.
Liang, Wei, et al.. (2006). Quantitative Determination of Olopatadine in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry. 27(4). 193. 3 indexed citations
18.
Hu, Pei. (2005). Quantitative Analysis of Proteins and Polypeptides by Mass Spectrometry. Yaowu fenxi zazhi. 1 indexed citations
19.
Hu, Pei. (2004). Rapid Evaluation of Rice Cooking and Palatability Quality by RVA Profile. ACTA AGRONOMICA SINICA. 30(6). 519–524. 16 indexed citations
20.
Ji, Jiang, et al.. (1999). The pharmacokinetics of lamivudine in healthy Chinese subjects. British Journal of Clinical Pharmacology. 48(2). 250–253. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ophelia Yin Breakdown of academic impact, for papers by Mark J. Rose Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by Joachim Stangier Breakdown of academic impact, for papers by Roland Valdes Breakdown of academic impact, for papers by Im‐Sook Song Breakdown of academic impact, for papers by Karl Zech Breakdown of academic impact, for papers by Donald J. L. Jones Breakdown of academic impact, for papers by Rashmi R. Shah Breakdown of academic impact, for papers by David Jones
Rankless by CCL
2026